Quality of life outcomes for patients with metastatic castration-resistant prostate cancer and pretreatment prognostic score.

Mosunmoluwa OyenugaSusan HalabiAbayomi OyenugaSean McSweeneyAlicia K MorgansCharles J RyanAnna Prizment

Published in: The Prostate (2023)

Chemotherapy-naïve mCRPC patients with poorer Halabi prognostic risk scores have poorer QOL and greater pain intensity and interference at baseline and during follow-up.

Keyphrases

chronic pain
pain management
neuropathic pain
high intensity
locally advanced
metabolic syndrome
spinal cord injury
glycemic control